References

  1. Tidwell JL, Seaman SA, Vanderploeg EJ, Tom S. In vitro and in vivo characterization of OSTEOAMP allogeneic morphogenetic proteins. Data on file, Bioventus white paper; 2017.
  2. Roh JS, Yeung CA, Field JS, McClellan RT. Allogeneic morphogenetic protein vs. recombinant human bone morphogenetic protein-2 in lumbar interbody fusion procedures: a radiographic and economic analysis. J Orthop Surg Res. 2013;8:49. doi:10.1186/1749-799X-8-49.
  3. Field J, Yeung C, Roh J. Clinical evaluation of allogeneic growth factor in cervical spine fusion. J Spine. 2014;3(158) doi:10.4172/2165-7939.1000158.
  4. Data on File.
  5. Scarpone MA, Kuebler D, Harrell DB. Marrow Cellution Bone Marrow Aspiration System and Related Concentrations of Stem and Progenitor Cells. (White Paper). Avon, MA: Ranfac Corporation Website. http://static1.squarespace.com/static/558b06c6e4b0396e7a146066/t/562556ece4b09867effe2d51/1445287660937/Marrow+Cellution+Scarpone+White+Paper.pdf. Accessed January 5, 2016.
  6. Yang SS. Compositions and Methods to Repair Osseous Defects. US Patent 6,228,386 (2001).
  7. Hench LL. The story of Bioglass. J Mater Sci Mater Med. 2006;17(11):967-78.
  8. Gerhardt LC, Boccaccini AR. Bioactive glass and glass-ceramic scaffolds for one tissue engineering. Materials. 2010;3(7):3867-910.
  9. Xynos ID, Edgar AJ, Buttery LDK, Hench LL, Polak JM. Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution. J Biomed Mater Res. 2001;55(2):151-7.
  10. Daculsi G, Layrolle P. Osteoinductive properties of micro macroporous biphasic calcium phosphate bioceramics. Key Eng. Mater. 2004;254-256:1005-1008.
  11. Daculsi G. Jegoux, Layrolle P. The micro macroporous biphasic calcium phosphate concept for bone regeneration and tissue engineering. Advanced Biomaterials: Fundamentals, Processing & Applications. 2009;Section 1,Chapter 4:101-142.
  12. Data on file. RPT-000541 BioStructures Technical Whitepapers.
  13. Garrido CA, Lobo SE, Turíbio FM, Legeros RZ. Biphasic calcium phosphate bioceramics for orthopaedic reconstructions: clinical outcomes. Int J Biomater. 2011;2011:129727.
  14. Cavagna R, Daculsi G, Bouler JM. Macroporous Calcium Phosphate Ceramic: A Prospective Study of 106 Cases in Lumbar Spinal Fusion. J Long-Term Effects Med Implants, 1999;9:403-12.
  15. Betz RR. Limitations of Autograft and Allograft: New Synthetic Solutions. Orthopedics 2002;25(5):561-70.
  16. Pettine KA, Murphy MB, Suzuki RK, Sand TT. Percutaneous injection of autologous bone marrow concentrate cells significantly reduces lumbar discogenic pain through 12 months. Stem Cells 2015;333(1)46-56.
  17. Hegde V, Shonuga O, Ellis S, et al. A prospective comparison of 3 approved systems for autologous bone marrow concentration demonstrated nonequivalency in progenitor cell number and concentration. J Orthop Trauma 2014;28(10):591-8.
  18. Data on file. RPT-000828 – OSTEOMATRIX+ Fluid Uptake Assessment.
  19. Daculsi G, Laboux O, Malard O, Weiss P. Current state of the art of biphasic calcium phosphate bioceramics. J Mater Sci Mater Med 2003;14(3):195-200.
  20. LeGeros RZ, Lin S, Rohanizadeh R, Mijares D, LeGeros JP. Biphasic calcium phosphate bioceramics: preparation, properties and applications. J Mater Sci Mater Med. 2003;14(3):201-9.
  21. Fellah BH, Gauthier O, Weiss P, Chappard D, Layrolle P. Osteogenicity of biphasic calcium phosphate ceramics and bone autograft in a goat model. Biomaterials.2008;29(9):1177-88.
  22. Data on file. RPT-000541 BioStructures Technical Whitepapers.
  23. Data on file RPT-000858. OSTEOAMP Absorption Data.
  24. Roberts T T, Rosenbaum A J. Bone grafts, bone substitutes and orthobiologics; the bridge between basic science and clinical advancements in fracture healing. Organogenesis. 2012;8(4):114-24. doi: 10.4161/org.23306.
  25. Hankenson KD, Dishowitz M, Gray C, Schenker M. Angiogenesis in bone regeneration. Injury. 2011;42(6):556-61. doi: 10.1016/j.injury.2011.03.035.
  26. Bioventus LLC. Data on file. RPT-000962. Osteoblast Differentiation Study.
  27. Brunelle JE, Seaman SA, Davis CT, Tom S. In vitro and in vivo characterization of SIGNAFUSE Bioactive Bone Graft. Data on file. Bioventus white paper, 2017.
  28. Ransford AO, Morley T, Edgar MA, et al. Synthetic porous ceramic compared with autograft in scoliosis surgery. A prospective, randomized study of 341 patients. J Bone Joint Surg Br. 1998;80-B:13-8. doi: 10.1302/0301-620x.80b1.7276
  29. Delécrin J, Takahashi S, Gouin F, Passuti N. A synthetic porous ceramic as a bone graft substitute in the surgical management of scoliosis: a prospective, randomized study. Spine (Phila Pa 1976). 2000;25(5):563-9. doi: 10.1097/00007632-200003010-00006
  30. Pascal-Moussellard H, Catonné Y, Robert R, Daculsi G. Anterior cervical fusion with PEEK cages: clinical results of a prospective, comparative, multicenter and randomized study comparing iliac graft and a macroporous biphasic calcium phosphate. Spine J. 2006;6(suppl 5):136S. Abstract P109. doi: 10.1016/j.spinee.2006.06.318
  31. Fredericks D, Peterson EB, Watson N, Grosland N, Gibson-Corley K, Smucker J. Comparison of two synthetic bone graft products in a rabbit posterolateral fusion model. Iowa Orthop J. 2016;36:167-73